Related Experiment Video
Updated: Apr 16, 2026

Teratoma Generation in the Testis Capsule
Published on: November 7, 2011
Testicular tumour - a review article
1Dr Sardar Rezaul Islam, Associate Professor, Department of Surgery, Jahurul Islam Medical College Hospital (JIMCH), Bajitpur, Kishoreganj, Bangladesh; E-mail: islamreza@ hotmail.com.
Painless scrotal masses require ultrasound and tumor markers before surgery. Testicular cancer incidence is rising, but improved treatments offer a better prognosis.
Area of Science:
- Oncology
- Urology
- Epidemiology
Background:
- Painless scrotal masses warrant prompt investigation.
- Testicular germ cell tumor incidence has doubled in Caucasian populations over 40 years, with an annual increase of 3-6%.
- Despite rising incidence, testicular cancer mortality rates are stable or decreasing due to treatment advancements.
Purpose of the Study:
- To review the epidemiology, presentation, classification, workup, staging, treatment, and prognosis of testicular tumors.
- To highlight testicular cancer as a model for solid tumor treatment.
Main Methods:
- Review of epidemiological data on testicular cancer incidence and mortality.
- Discussion of diagnostic workup including ultrasound imaging and tumor marker assays.
- Overview of treatment modalities such as radical inguinal orchidectomy, chemotherapy, and stem cell rescue.
Main Results:
- Testicular cancer incidence is increasing, particularly in Caucasian men.
- Mortality rates have decreased due to effective treatments.
- Advanced therapies have significantly improved the prognosis for metastatic testicular cancer.
Conclusions:
- Early investigation of painless scrotal masses is crucial.
- Testicular cancer management has seen remarkable progress, improving patient outcomes.
- Testicular cancer serves as a successful model for solid tumor treatment strategies.
More Related Videos
07:34Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking
Published on: November 17, 2023
07:25A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018